Navigation Links
Kendle to Present at 2010 Wells Fargo Securities Healthcare Conference
Date:6/17/2010

CINCINNATI, June 17 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization, today announced the Company will participate in the upcoming 2010 Wells Fargo Securities Healthcare Conference on June 23, 2010, at the InterContinental Hotel in Boston.

Kendle's formal presentation will be given by Chairman and Chief Executive Officer Candace Kendle, PharmD, at 1 p.m. Eastern Time.

The presentation will be webcast and may be accessed at www.kendle.com in the "Investors Events & Presentations" section or at www.wsw.com/webcast/wa61/kndl/

Slides will be available by 10 a.m. on the day of the presentation at www.kendle.com in the "Investors Events & Presentations" section.

About Kendle

Kendle International Inc. (Nasdaq: KNDL) is a leading global clinical research organization providing the full range of early- to late-stage clinical development services for the world's biopharmaceutical industry. Our focus is on innovative solutions that reduce cycle times for our customers and accelerate the delivery of life-enhancing drugs to market for the benefit of patients worldwide. As one of the world's largest global providers of Phase I-IV services, we offer experience spanning more than 100 countries, along with industry-leading patient access and retention capabilities and broad therapeutic expertise, to meet our customers' clinical development challenges.

Additional information and investor kits are available upon request from Kendle, 441 Vine Street, Suite 500, Cincinnati, OH 45202 or from the Company's Web site at www.kendle.com.


'/>"/>
SOURCE Kendle International Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Kendle Advances Early Stage Drug Development with ElMindAs Innovative Brain Network Activation Technology
2. Kendle Director of Global Safety and Pharmacovigilance, Drew Kilpatrick, PhD, Named One of Ten Notable People in R&D
3. Kendle Executive to Share Insights at World Pharma Trials Asia 2010
4. Kendle is First Global CRO to Achieve ISO 9001:2008 Certification in China Through Beijing Affiliate
5. Kendle Launches New Global Biostatistics Infrastructure
6. Kendle Receives Approval From Indian Government to Proceed With Development of Operations Center in Special Economic Zone
7. Kendle Appoints J. Michael Sprafka, MPH, PhD, Vice President, Kendle Consulting
8. Kendle Announces Details Regarding Third Quarter 2009 Earnings Conference Call and Webcast
9. Kendle Experts to Share Insights at the Regulatory Affairs Professionals Society Annual Conference and Exhibition
10. Kendle Experts to Present at the Drug Information Association 44th Annual Meeting
11. Regado Biosciences to Present at the 2010 Wells Fargo Healthcare Conference on June 24, 2010 in Boston, Massachusetts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/5/2017)... , Oct. 5, 2017  In response ... of Oral and Maxillofacial Surgeons (AAOMS) released prescribing ... – to be used as a first-line therapy ... Recognizing the ... AAOMS White Paper "Opioid Prescribing: Acute and Postoperative ...
(Date:10/4/2017)... Oct. 4, 2017  According to the Centers for Disease Control and ... October . PhysicianOne Urgent Care is helping communities across Massachusetts ... , by offering no-cost* flu shots through the end of the ... certain health insurance regulations. ... time to get a flu shot is by the end of October, ...
(Date:10/2/2017)... , Oct. 2, 2017 Diplomat Pharmacy, Inc. ... Day Software and Consulting, LLC , and named its ... Software, based in Tennessee , will ... Day expands EnvoyHealth,s service offerings for health care partners ... "In an interoperable world, ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( ... today the introduction of an innovative new design of the shoulder pad. The ... get maximum comfort while controlling your pain while using cold therapy. By utilizing ice ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... system that we intend to develop to enable prevention of a major side ... severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA ...
(Date:10/12/2017)... ... ... Leading pediatric oncology experts at Children’s National Health System will join ... International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by Jeffrey Dome, ... at Children’s National, and Stephen P. Hunger, M.D., Chief of the Division of ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health Literacy Innovations ... literacy software tool, and the Cancer Patient Education Network (CPEN), an independent professional ... announce a new strategic alliance. , As CPEN’s strategic partner, HLI will ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... Dining at the University of California Berkeley, and other leading institutions in announcing ... buying power of institutions to change the way animals are raised for food. ...
Breaking Medicine News(10 mins):